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OBJECTIVES: To analyze and compare the evolution of hematological parameters and body iron content
between exclusively breastfed late-preterm and term newborns during the first two months of life.
METHODS: Cohort study. Weight, length, head circumference, body mass index, hemoglobin, hematocrit,
reticulocytes, total iron-binding capacity, transferrin saturation, serum iron and ferritin were measured in 25
late-preterm and 21 term newborns (at birth and at one and two months of age) who were exclusively
breastfed. Statistical analysis: Kolmogorov-Smirnov test, one-way ANOVA or Kruskal-Wallis test; and Student’s
t-test or Mann-Whitney test. Significance: p,0.05.
RESULTS: The corrected gestational ages of the late-preterm infants were 39.98 weeks at one month of life and
44.53 weeks at two months. Anthropometric measures and the body mass index increased over time (p,0.001)
and hemoglobin, hematocrit, reticulocytes and body iron content decreased (p,0.001). Late-preterm infants at
term corrected gestational age had reduced hemoglobin, hematocrit and reticulocyte concentrations, and
reduced total iron-binding capacity (p,0.001) and serum iron (p=0.0034) compared with values observed in
term newborns at birth. Late-preterm newborns at a corrected gestational age of one month post-term had
hemoglobin (p=0.0002), hematocrit (p=0.0008), iron (p,0.0001) and transferrin saturation (p,0.001) levels
lower than those of term newborns at one month of age and a higher total iron-binding capacity (p=0.0018).
Ferritin did not differ between the groups.
CONCLUSION: Exclusively breastfed late-preterm newborns presented greater reductions in hemoglobin/
hematocrit and lower iron stores at a corrected gestational age of one month post-term than did term
newborns, suggesting specific iron supplementation needs.
KEYWORDS: Anemia; Hemoglobin; Iron; Newborns; Preterm Infants.
Yamada RT, Leone CR. Hematological and iron content evolution in exclusively breastfed late-preterm newborns. Clinics. 2014;69(12):792-798.
Received for publication on July 7, 2014; First review completed on August 11, 2014; Accepted for publication on August 25, 2014
E-mail: renato.yamada@ig.com.br
*corresponding author: renatotyamada@gmail.com
Tel.: 55 11 2414-2342
& INTRODUCTION
Iron is a trace element found at high levels in the human
body (1) that participates in various metabolic pathways,
especially erythropoiesis and neurodevelopment (2). Modifica-
tions in these reactions can modify sensorimotor, cognitive/
language, social/emotional and psychological/behavioral
activities during brain development in newborns (2).
Approximately 80% of fetal iron storage is deposited during
the third trimester of gestation (3); this storage is fundamental
to the formation of hemoglobin (Hb), which is responsible for
transporting oxygen to tissues. Hb levels in the fetus increase
during pregnancy, with high concentrations observed at
birth. However, after birth, polycythemic conditions, a
decrease in fetal Hb, an increase in adult-type Hb, higher
environmental oxygen concentrations and Hb oxygen satura-
tion promote great tissue oxygenation and thus decrease the
stimulation of erythropoietin production (4), reducing eryth-
rocyte release.
Therefore, the Hb level is reduced by approximately 30 to
50%, reaching a nadir at six to twelve weeks after birth in
term infants and one to four weeks earlier in preterm infants
(5). Certain conditions may explain this difference, such as
frequent blood sampling for laboratory tests; an immature
erythropoietic response; low sensitivity of hypoxemia
sensors; folate, vitamin B12 and E (antioxidant erythrocyte)
deficiencies; and a volume expansion of the blood cell mass
due to rapid postnatal growth (6).
Considering that preterm infants are born before their
fetal storage is complete, they may develop an increased
risk of iron deficiency and even anemia during the early
postnatal period (7).
Late-preterm (LPT) newborns, despite appearing healthy,
are premature and carry all of the inherent risks, such as
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increased difficulty in the postnatal transition and a greater
risk of neonatal morbidity compared with term newborns,
in addition to a higher incidence of readmissions (approxi-
mately two times higher) and neonatal mortality (8). This
risk is reflected in the neonatal mortality rates of LPT
newborns and term newborns, which were 7.7/1000 live
births and 2.5/1000 live births, respectively, in 2002 in the
United States (8). Additionally, the long-term effects of late
prematurity suggest higher morbidity associated with
neurodevelopment, with delayed brain development in
early childhood, cerebral palsy and low academic profi-
ciency (9).
Evidence available in the literature indicates that exclu-
sively breastfed term newborns have sufficient hepatic iron
reserves for growth and development and do not require
supplementation before the sixth month of life. LPT new-
borns may be born with lower nutrient reserves, including
total body iron, which can influence postnatal hematological
evolution, requiring iron treatment or replacement. Based
on this information, a study was developed to analyze and
compare the evolution of hematological parameters and
body iron content between exclusively breastfed LPT and
term newborns during the first two months of life.
& METHODS
A cohort study was carried out between March 2009 and
December 2011 at a tertiary public hospital in Sa˜o Paulo,
Brazil and approved by the Ethics Committee for Research
Analysis (CAPPesq) of the Clinical Board of the Hospital
das Clı´nicas da Faculdade de Medicina da Universidade de
Sa˜o Paulo.
In total, 21 term newborns (gestational age (GA) between
37 weeks and 41 weeks, 6 days) (10) and 25 LPT newborns
(GA between 34 weeks and 36 weeks, 6 days) (11) who were
exclusively breastfed were included. Informed consent
forms for the study were signed by legally authorized
representatives.
The exclusion criteria comprised congenital malforma-
tions; genetic abnormalities and congenital or perinatal
infections; twins; Apgar scores #3 at one minute or #7 at
five minutes; newborns under the 10th and above the 90th
percentile according to the curve reported by Alexander
et al. (12); fasting; blood transfusion; hemolytic anemia;
maternal diseases or complications that could interfere with
iron metabolism, such as malnutrition, heart disease, skin
disorders, lung diseases, gastrointestinal diseases, acute
infection during childbirth or within ten days before birth,
hemoglobinopathies, diabetes and hypo/hyperthyroidism;
and maternal smoking or drug use.
The infants were divided into two groups: Group 1 (G1)
included LPT newborns and Group 2 (G2) included term
newborns.
Blood samples were collected at birth (from the umbilical
cord) and at one month and two months of age. The at-birth
blood sample was collected after umbilical cord clamping
within the first 30 seconds after birth. Anthropometric
measurements (weight, length and head circumference)
were performed and the body mass index (BMI) was
calculated within the first 24 hours of life and at the
chronological ages of one month and two months of age
for term newborns and at corrected GAs of term and one
month post-term (post-T) for LPT newborns. All anthropo-
metric measurements were performed by the researchers,
including blood sample collections. All infants were
followed at the specialized outpatient department of the
same hospital. The parents were asked about social factors,
breastfeeding techniques and medication taken by the child
or by the mother. The mothers received 300 mg of iron
supplementation for two months after delivery. The infants
started receiving iron supplementation (2 mg per kilogram
per day) after two months of age. When Hb levels or iron
stores were found to be low at one month of life, those
patients were excluded and their iron-deficiency anemia
was treated.
Laboratory tests were conducted at the Laborato´rio de
Ana´lises Clı´nicas do Instituto da Crianc¸a (Clinical Analysis
Laboratory of the Child Institute of the Faculdade de
Medicina da Universidade de Sa˜o Paulo, Brazil). Hb,
hematocrit (Ht) and reticulocyte tests were performed using
the Roche Diagnostics Sysmex XT-2000i Automated
Hematology Analyzer. The ferritin levels (immunoturbidi-
metric method), serum iron (Guanidine/FerroZineH
method) and total iron-binding capacity (TIBC) (automated
method) were evaluated using the Siemens Dimension RxL
system. Transferrin saturation (TfSat) was calculated using
the following equation: iron/TIBC.
Statistical analysis
The sample size comprised 20 infants in each group and
was chosen based on the assumption that the groups to be
compared would have an approximate difference of 30%,
using a= 5% and a power of 80%. The mean values and
standard deviations found in the literature for Hb
(15.2¡1.5 g/dl) (13) and ferritin (173¡59 ng/ml) (14) in
term and LPT newborns were considered and differences of
1.5 g/dl for Hb and 59 ng/ml for ferritin between the
groups were deemed necessary for significance. The
definition of anemia for statistical analysis was based on
Hb levels below 10.5 g/dl (15,16).
The results are reported as means and standard devia-
tions. The Kolmogorov-Smirnov test was used to evaluate
normality. The Kruskal-Wallis test was used to evaluate
differences when the distribution was not normal. A
homogeneity test was used to check the equality of
variances between the groups when the distribution was
considered normal. One-way analysis of variance (ANOVA)
was performed when the distribution was considered
normal. Otherwise, the robust Brown-Forsythe test for
equality of means was applied to evaluate differences
(p,0.05). The comparison of means was performed using
Student’s t-test or the Mann-Whitney test. A box plot was
used to analyze the distribution of the Hb values at term
and one month post-T and the differences between groups.
The results were considered statistically significant if
p,0.05. SPSS v17 software (Statistical Package for the
Social Sciences version 17.0, SPSS Inc., Chicago, IL, 1999)
and GraphPad InStat (version 3.10, GraphPad Software Inc.,
La Jolla, CA) were used for data processing.
& RESULTS
There were no differences between the groups regarding
maternal characteristics (Table 1), except that pregnancy
complications were more frequent in the LPT group
(p,0.001), especially premature labor and amniorrhexis.
Regarding the characteristics of the newborns (Table 1),
all of them had early umbilical cord clamping (,30
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seconds). The mean GA at birth was 35.67¡0.92 weeks
among the LPT newborns and 39.7¡1.01 weeks among the
term newborns, with a significant difference between the
groups (p,0.001). LPT newborns had corrected GAs of 39.98
weeks at one month of life and 44.53 weeks at two months.
All infants showed increases in weight, length, head
circumference and BMI (p,0.001) (Table 2), although these
measures were lower in preterm infants. However, LPT
infants at term corrected GA had a greater length and head
circumference (p= 0.0043 and p,0.001, respectively) than
did term newborns at birth and at one month post-T, as well
as a lower BMI (p= 0.0013) than that of term newborns at
birth. Only the head circumference of the LPT infants was
greater than that of the term infants at one month of age
(p= 0.0028).
Hb and Ht (Table 3) mainly decreased in the LPT
newborns (p,0.001). At birth, a difference between the
two groups was observed only for Ht (p= 0.010), whereas at
two months, more dramatic differences in both Hb
(p= 0.020) and Ht (p,0.001) were present. At corrected
GAs of both term and one month post-T, the concentrations
of Hb and Ht in the LPT newborns were lower than those in
the term newborns (Table 3). Box plot analysis indicated
greater dispersion values for LPT newborns at term
corrected GA than for term newborns at birth, whereas
the dispersion was greater for term newborns at one month
of age than for LPT newborns at a corrected GA of one
month (Figures 1 and 2). In both analyses, the median Hb
values were higher in term newborns compared with LPT
newborns at either term corrected GA (p,0.001) or a
corrected GA of one month post-T (p= 0.0013).
The incidence of anemia was 66.67% in LPT newborns at a
corrected GA of one month post-T and 41.18% in term
newborns at one month of age (p= 0.02).
Table 1 - Population characteristics of late-preterm and term newborns.
G1 (LPT) G2 (term) p
n=25 n=21
Mother’s age 25.96¡8.37 24.00¡7.40 0.337
First pregnancy 12 (48%) 11 (52.38%) 0.471
Cesarean section 9 (36%) 9 (42.86%) 0.417
Disease/complications 36 6 ,0.001
Preterm labor 19 0 ,0.001
Premature amniorrhexis 4 1 0.116
Gestational age (weeks) 35.67¡0.92 39.75¡1.01 ,0.001
Male (%) 16 (64%) 11 (52.38%) 0.370
Apgar 1st minute.4 and 5th minute.6 25 (100%) 21 (100%) -
Age at first return (days) 30.46¡1.74 (n= 24) 30.52¡2.18 (n = 21) 0.830
Age at second return (days) 61.62¡3.12 (n= 21) 61.33¡1.32 (n = 21) 0.565
Corrected GA at first return (weeks) 39.98¡0.95 - -
Corrected GA at second return (weeks) 44.53¡1.11 - -
GA: Gestational age; LPT: Late preterm.
Table 2 - Weight, length, head circumference and body mass index of late-preterm and term newborns during the first
two months of life, with the corrected gestational age for the late-preterm newborns.
Weight (g) G1 (LPT) G2 (term) p p
At birth 2603.00¡357.56 3404.00¡347.75 ,0.001 -
1 month/term* 3225.83¡514.09 4305.71¡458.25 ,0.001 0.2502{
2 months/1 month post-T** 4461.43¡575.74 5426.43¡638.10 ,0.001 0.3249{{
p¤ ,0.001 ,0.001
Length (cm) G1 (LPT) G2 (term) p p
At birth 45.48¡1.97 48.71¡1.02 ,0.001 -
1 month/term* 50.10¡1.85 53.90¡1.59 ,0.001 0.0043{
2 months/1 month post-T** 54.14¡1.70 57.86¡1.46 ,0.001 0.6444{{
p¤ ,0.001 ,0.001
HC (cm) G1 (LPT) G2 (term) p p
At birth 32.80¡1.06 34.57¡0.90 ,0.001 -
1 month/term* 35.60¡1.02 37.57¡0.97 ,0.001 0.0010{
2 months/1 month post-T** 38.38¡0.84 39.43¡1.09 ,0.001 0.0028{{
p¤ ,0.001 ,0.001
BMI (kg/m2) G1 (LPT) G2 (term) p p
At birth 12.54¡1.10 14.34¡1.30 ,0.001 -
1 month/term* 12.80¡1.50 14.79¡1.01 ,0.001 0.0013{
2 months/1 month post-T** 15.20¡1.65 16.19¡1.60 ,0.001 0.3199{{
p¤ ,0.001 ,0.001
*Corrected gestational age (GA) of term for late-preterm (LPT) newborns.
**Corrected GA of 1 month post-term (post-T) for LPT newborns.
{p-value for a corrected GA of term for LPT newborns versus at birth for term newborns.
{{p-value for a corrected GA of 1 month post-T for LPT newborns versus 1 month of age for term newborns.
¤p-value for the evolution over time of each hematological parameter.
HC = Head Circumference.
BMI = Body Mass Index.
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Reticulocyte concentrations (Table 3) presented similar
variations in the two groups, decreasing at one month and
increasing at two months. These concentrations were also
higher in the LPT newborns throughout the study period.
The reticulocyte concentrations in the term newborns were
higher than those in the LPT newborns at term corrected GA
and lower than those in the LPT newborns at a corrected GA
of one month post-T (p,0.001).
All markers of iron stores varied throughout the two
months (Table 4). In LPT newborns, serum iron increased at
one month and declined at two months (p,0.001). There
were differences between the groups at birth (p,0.001) and
at two months of age (p= 0.020) and lower concentrations
were observed in the LPT newborns. The iron concentra-
tions in the LPT newborns were lower at term corrected GA
(p= 0.0034) and at a corrected GA of one month post-T
(p,0.001).
TIBC increased over time (p,0.001). Lower levels were
measured in the LPT newborns at birth (p,0.001) and at
term corrected GA (p= 0.0001), although the levels were
higher at a corrected GA of one month post-T (p= 0.0018).
Table 3 - Hemoglobin, hematocrit and reticulocytes in late-preterm and term newborns during the first two months of
life, with the corrected gestational age for the late-preterm newborns.
Hb (g/dl) G1 (LPT) G2 (term) p p
At birth 15.70¡1.80 15.96¡1.40 0.600 -
1 month/term* 10.83¡1.84 11.95¡1.96 0.060 ,0.001{
2 months/1 month post-T** 9.59¡1.50 10.55¡0.90 0.020 0.002{{
p¤ ,0.001 ,0.001
Ht (%) G1 (LPT) G2 (term) p p
At birth 44.21¡5.22 48.60¡5.04 0.010 -
1 month/term* 30.45¡5.00 33.58¡5.46 0.060 ,0.001{
2 months/1 month post-T** 27.04¡3.86 30.55¡2.52 ,0.001 0.008{{
p¤ ,0.001 ,0.001
Ret (%) G1 (LPT) G2 (term) p p
At birth 5.34¡1.18 3.34¡1.25 ,0.001 -
1 month/term* 1.71¡1.18 0.79¡0.40 ,0.001 ,0.001{
2 months/1 month post-T** 2.40¡0.90 1.40¡0.85 ,0.001 ,0.001{{
p¤ ,0.001 ,0.001
*Corrected gestational age (GA) of term for late-preterm (LPT) newborns.
**Corrected GA of 1 month post-term (post-T) for LPT newborns.
{p-value for a corrected GA of term for LPT newborns versus at birth for term newborns.
{{p-value for a corrected GA of 1 month post-T for LPT newborns versus 1 month of age for term newborns.




Figure 1 - Hemoglobin levels of late-preterm newborns at term
corrected gestational age and of term newborns at birth.
Figure 2 - Hemoglobin levels of late-preterm newborns at a
corrected gestational age of one month and of term newborns
at one month of age.
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TfSat decreased in a pattern similar to that of the TIBC.
TfSat was lower in LPT newborns at birth (p,0.001) and at a
corrected GA of one month post-T (p,0.001).
Ferritin changed over time and no differences were
observed between the groups at any time point in the study,
even when corrected GA was considered. Nevertheless, it
was observed that the difference approached statistical
significance (p= 0.0529) at one month post-T in LPT new-
borns compared with term newborns at one month of age.
& DISCUSSION
Analysis of the hematological parameters and iron
content in exclusively breastfed term and LPT newborns
during the first two months of life revealed greater
reductions in Hb and Ht concentrations and smaller
reserves of iron in the LPT newborns until a corrected GA
of one month compared with the term newborns. These
results suggest that LPT newborns have increased iron
needs after birth.
The fact that the study groups were homogeneous with
regard to maternal characteristics, particularly age, parity,
prenatal care and the incidence of cesarean section, support
the relevance of the above-mentioned differences. The higher
frequency of pregnancy complications in the LPT newborn
group, including premature labor and amniorrhexis, could
be considered as expected events that contributed toward the
early interruption of pregnancy.
In the same way, both groups only differed with respect
to GA, which was significantly lower in the LPT newborns
compared with the term newborns (p,0.001), as expected
from the study design. The corrected GA of the LPT
newborns at one month of life was 39.77¡1.30 weeks, which
was close to the GA of the term newborns at birth, whereas
at two months of age, the LPT newborns had a corrected GA
of one month post-T.
During postnatal development, all infants exhibited
increases in weight, length, head circumference and BMI
(p,0.001) at an expected rate and it can therefore be
concluded that they received enough breast milk to meet
their needs. An analysis based on the corrected GA revealed
significant growth in the length and head circumference of
both groups, although the LPT measurements were higher
at term corrected GA than in the term newborns at birth.
Only head circumference remained higher at a corrected GA
of one month post-T than in the term newborns (p= 0.0028).
This fact indicated that the LPT newborns must have
achieved excellent growth to have reached a weight at term
corrected GA similar to that of the term newborns at birth
and at one month of life. Head circumference was greater
than in term newborns during both assessments, indicating
favorable growth of the central nervous system.
The more intense reduction in Hb and Ht and the increase
in reticulocytes observed during all assessments (p,0.001)
in the LPT newborns might signal the presence of intense
bone marrow stimulation for erythropoiesis, as is expected
at this corrected GA.
Analysis of the reductions in Hb indicated a high
incidence of anemia in the LPT newborns. This finding
reinforced the intense reduction in Hb observed in these
newborns and the consequent risk of anemia.
The median Hb value observed in term newborns
exceeded the 75th percentile of LPT newborns at each
corrected GA in the study. Although these differences
decreased from term corrected GA to a corrected GA of one
month post-T, this difference could have been a conse-
quence of the earlier nadir of anemia in LPT newborns, as is
commonly observed during the first months of life and their
recovery.
Early umbilical cord clamping, less than 30 seconds after
birth, was likely an additional factor contributing to the high
incidence of anemia observed in both groups (17).
Table 4 - Serum iron, total iron-binding capacity, ferritin and transferrin saturation in late-preterm and term newborns
during the first two months of life, with a corrected gestational age for the late-preterm newborns.
Serum iron (mg/dl) G1 (LPT) G2 (term) p p
At birth 49.17¡26.12 133.95¡58.90 ,0.001 -
1 month/term* 86.83¡20.16 93.47¡24.12 0.330 0.0034{
2 months/1 month post-T** 58.24¡22.48 75.89¡25.31 0.020 ,0.001{{
p¤ ,0.001 ,0.001
TIBC (mg/dl) G1 (LPT) G2 (term) p p
At birth 209.08¡47.66 280.19¡63.38 ,0.001 -
1 month/term* 211.58¡59.48 241.89¡42.78 0.070 0.0010{
2 months/1 month post-T** 297.52¡63.70 301.00¡61.48 0.860 0.0018{{
p¤ ,0.001 ,0.001
TfSat (%) G1 (LPT) G2 (term) p p
At birth 24.79¡16.06 47.69¡17.54 ,0.001 -
1 month/term* 44.12¡17.27 39.77¡11.93 0.360 0.5169{
2 months/1 month post-T** 20.94¡10.52 26.94¡12.09 0.100 ,0.001{{
p¤ ,0.001 ,0.001
Ferritin (mg/l) G1 (LPT) G2 (Term) p p
At birth 215.96¡132.56 167.86¡112.71 0.200 -
1 month/term* 226.96¡119.95 232.11¡136.64 0.900 0.1150{
2 months/1 month post-T** 152.10¡109.66 157.05¡95.83 0.880 0.0529{{
p¤ ,0.001 ,0.001
*Corrected gestational age (GA) of term for late-preterm (LPT) newborns.
**Corrected GA of 1 month post-term (post-T) for LPT newborns.
{p-value for a corrected GA of term for LPT newborns versus at birth for term newborns.
{{p-value for a corrected GA of 1 month post-T for LPT newborns versus 1 month of age for term newborns.
¤p-value for each hematological parameter.
TIBC = Total iron-binding capacity.
TfSat = Transferrin saturation.
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Regarding body iron content markers, they were mod-
ified in both groups over time (p,0.001). Considering the
corrected GA, LPT newborns at term and one month post-T
had lower levels than those of term newborns, suggesting
reduced iron availability in these infants. Nonetheless, the
differences were only found at birth, when lower levels
were verified in the LPT newborns (p,0.001). These
differences between the groups cannot be considered alone
because serum iron is a less accurate indicator of iron
reserves and may be influenced by several factors, such as
stress, inflammatory processes, the release of erythrocytes
by lysis and the mobilization of iron storage, among others
(18).
In addition to their concentrations being within normal
limits at two months, in LPT newborns, TIBC evolution after
birth was within normal limits, according to the reference
values of 250 to 390 mg/dl (19). The highest levels reached at
one month post-T may reflect the beginning of an iron
deficiency, which could have been the result of the higher
growth rates observed in this period and a possible
insufficient supply of iron.
TfSat is not a specific measure for determining iron
reserves; however, levels above 20 to 25% exclude iron
deficiency (20). TfSat was higher than 20% at birth in both
groups, although the LPT values were much lower than
those of the term newborns. As mentioned, the beginning of
an iron deficiency could also be indicated by the hemato-
logical parameters and iron content evolution over one
month post-T, according to the corrected GA, for LPT
newborns reaching minimal acceptable levels, along with
the intense decrease in Hb and increase in reticulocytes
beyond the elevation of the TIBC, reinforcing this hypoth-
esis.
Ferritin is considered a reference marker of iron storage,
but its concentrations are hardly affected by the depletion of
iron stores (21), which might partly explain the similarity
observed between the groups and the large standard
deviation found. In our study, the values found at birth
for both term and LPT newborns were similar to those
described in a recent review published by Lorenz et al. (22).
After birth, ferritin levels decreased until two months of age
in both groups. This evolution further strengthens the
hypothesis of iron deficiency during a phase when a ferritin
increase was expected following physiological hemolysis
and iron release from internal stores (16).
In LPT newborns, lower concentrations of iron markers
were observed at corrected GAs of term and one month
post-T than those in term newborns. These results reinforce
the evidence supporting reduced iron reserves in this group
of infants, due to both the absence of an adequate iron
supply during the third gestational trimester and possibly
insufficient postnatal intake (22).
Nevertheless, if we consider that brain development may
be compromised by low iron stores involving ferritin levels
lower than 35 mg/l (23), there would have been no risk of
injury to the central nervous system in our study because
the values obtained were higher than 35 mg/l, at least the
time period studied.
Based on these data, a pattern of accelerated growth and
differences between the LPT and the term newborns were
observed along with a reduction in hematological values,
which could have been influenced by prematurity.
The inability to extend the clinical follow-up and the
adversities encountered during medical care, including
family problems, constituted research restrictions. Another
possible limitation of this study was the lower significance,
based on the large standard deviation found and the study
of iron markers other than ferritin, which did not exhibit
significant differences in our results.
Despite maternal iron supplementation during prenatal
care and the first two months after delivery, our results
revealed reduced stores of iron during this period in the
newborns, which could indicate chronic iron deficiency.
Considering exclusively breastfed LPT newborns, we
recommend closely monitoring hematological parameters
and iron content evolution during the first months of life.
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